
    
      This special drug use surveillance was designed to evaluate the effectiveness (endpoints:
      frequency of bone fractures, percent change from baseline in bone density, etc.) and safety
      of sodium risedronate 75 mg tablets in osteoporosis patients in daily medical practice.

      The usual dosage for adult is 75 mg of sodium risedronate administered orally with a
      sufficient volume (approximately 180 mL) of water once monthly after waking.
    
  